Amzak Health
Venture capitalNew York · Seed–Late Stage · 5 people tracked
Investment thesis
Amzak Health invests in life science innovation, targeting first-in-class and best-in-class technologies within medtech and biotech. The firm positions itself as more than just capital, acting as a partner to its portfolio companies and working alongside management teams to help them succeed. It operates as a small team of biotech and medtech investors with substantial investing and operating experience and a track record of success.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & public directories
What they invest in
from 19 of 19 portfolio companiesHealthtech ×17Medical Devices ×16Biotech ×9Hardware ×7Deep Tech ×2Digital Health ×2FemTech ×2AI & Machine Learning ×1
HQs:United States×9United Kingdom×1
Investments · 19 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 22024 · 22016 · 16 dated
Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Markus Warmuth(M.D., Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)John Castle(Ph.D., Chief Data and Information Officer)Filip Janku(M.D., Ph.D., Chief Medical Officer)Phil Nickson(Ph.D., J.D., Chief Business and Legal Officer)Magnus Walter(DPhil, Chief Technology Officer)
Co-investorsAisling CapitalNew Enterprise Associates (NEA)Versant VenturesHBM PartnersAvoro Capital AdvisorsGV (Google Ventures)+1 more
Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).
BiotechDigital HealthMedical Devices
Paul F. Truex(Chairman of the Board & Chief Executive Officer)Debra Odink(President & Chief Development Officer)Amy Sehnert(Chief Medical Officer)Matt Killeen(Chief Business Officer)
BoardSaumya Das(Chief Scientific Advisor)
Co-investorsLumira VenturesadMare BioInnovationsCTI Life Sciences Fund L.P.Fonds de solidarité FTQ
BridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support.
BiotechHealthtech
Co-investorsAisling CapitalEcoR1 CapitalFrazier Life SciencesHEALTHCARE ROYALTY PARTNERSLongwood FundSequoia Capital
Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.
HardwareHealthtechMedical DevicesRaleigh, US
Ravish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)
Co-investorsLightstone VenturesHatteras Venture PartnersMountain Group CapitalUS Venture Partners
FemTechHealthtechMedical DevicesRedwood City, US
Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)Tom Rodgers(Director)
BoardKen Haas(Director)Jonathan MacQuitty(Director)inMike Carusi(Director)in
Co-investorsBain Capital Life SciencesEndeavour VisionFemHealth VenturesKaiser Permanente VenturesKluz VenturesLightstone Ventures+5 more
HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.
BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB
Wen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)James Adox(Director)Thomas Davison(Executive Officer, Director)
Co-investorsAlpha Wave GlobalEarly Stage Partners, LPHealthQuest CapitalLumira VenturesMichigan Capital NetworkBezos Expeditions+2 more
Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics.
BiotechHardwareHealthtechMedical DevicesDublin 2, US
Shlomo Ben-Haim(Director)Jason Spees(Chief Executive Officer)Paul Bae(Chief Administrative Officer and General Counsel)Rui Yang(Director)David Prutchi, Ph.D.(Executive Officer)Daniel Scavilla(Director)
Co-investorsEssex Woodlands Healthcare PartnersSignet Healthcare Partners
Inspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective.
Digital HealthHealthtechMedical DevicesGolden Valley, US
Timothy Herbert(Executive Officer, Director)Tim Herbert(Founder)inJerry Griffin(Director)Gary Brothers(Director)Mudit Jain(Director)Marilyn Nelson(Director)
Co-investorsAPERTURE Venture PartnersUS Venture PartnersOrbiMed
KOKO Medical is a development-stage medical device startup building a catheter-based device that encourages uterine contractions and removes excess blood to treat postpartum hemorrhage.
FemTechHealthtechMedical Devices
Skott Greenhalgh(Co-Founder & Chief Executive Officer)Michael Wallace(Co-Founder & Chief Technology Officer)Jason Keiser(Co-Founder & VP of Operations)
Miach Orthopaedics develops implants that help the body restore its own connective tissue, with an initial focus on treating ACL tears.
HealthtechMedical DevicesWestborough, US
Martha Murray(Founder)Chris Joyce(Executive Officer)Patrick McBrayer(Executive Officer, Director)Sean Sansiveri(Director)Pieter Wolters(Director)
BoardMarc-Andre Marcotte(Director)
Co-investorsAPERTURE Venture PartnersEndeavour VisionSV Health Investors
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.
HardwareHealthtechMedical Devices
Co-investorsFoothill VenturesLumira VenturesShangBay Capital LLCUS Venture Partners
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)
BoardJoyce Erony(Director)inWilliam Harrington(Director)
Co-investorsAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart VenturesRiverVest Venture Partners+5 more
NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model.
Deep TechHealthtechMedical Devices
Co-investorsTreo Ventures, LlcAPERTURE Venture PartnersNorwest Venture PartnersOSF VenturesU.S. Venture Partners
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)Brad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)
Co-investorsAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF VenturesSeroba Life Sciences+3 more
SoundBlade Medical develops handheld histotripsy technology for non-invasive surgery, using focused ultrasound to treat tissue with precision.
HardwareHealthtechMedical Devices
Jeremy Brown(Co-Founder & CTO)inMatt Mallay(Co-Founder & Sr. Dir. R&D)inAndre Bezanson(Co-Founder & Dir. R&D)inEli Vlaisavljevich(Co-Founder)inRick Balys(Co-Founder)inNeil Barman(Chief Executive Officer)in
Co-investorsLumira VenturesInvest Nova Scotia
Synergy Spine Solutions is a medical device company that develops motion-preserving spine technologies for treating degenerative disc disease.
HardwareHealthtechMedical Devices
4D Molecular Therapeutics develops genetic medicines using a directed-evolution vector platform to create customized AAV vectors optimized for specific diseases.
BiotechHealthtech
Co-investorsBerkeley CatalystBOLD LongevityPfizer Venture Investments
Exits · 3
IPOs and acquisitions across the tracked portfolioMonte Rosa TherapeuticsNASDAQ: GLUETeleflexNYSE: TFXGynesonicsacq. by Hologic
Portfolio news
latest coverage across their companiesInspire Medical · themarketsdaily.com · Aug 19, 2026
Nervonik · citybiz.co · Apr 28, 2026
NuXcel · finsmes.com · Nov 11, 2025
Neuros Medical · finance.yahoo.com · Jul 10, 2025
Frequently asked questions
- How many investments has Amzak Health made?
- Amzak Health has 16 tracked investments, 1 of which have exited via acquisition or IPO, including 3 dated in the last 24 months.
- What stage does Amzak Health invest at?
- Amzak Health invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Amzak Health focus on?
- Amzak Health focuses on Biotech, Digital Health, FemTech, Healthtech, Medical Devices.
- Where is Amzak Health located?
- Amzak Health is headquartered in New York, US.
- Who does Amzak Health co-invest with?
- Amzak Health most often shares deals with APERTURE Venture Partners, US Venture Partners, Aisling Capital, among 40 tracked co-investors.
Images
Co-investors · 3
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Access Industries is a private holding company and global investment firm founded in 1986 by Len Blavatnik that identifies companies with strong business models and management teams to optimize their value through financial backing and strategic expertise.
Access Biotechnology invests in private and public biopharma companies developing transformative therapies for conditions with high unmet medical needs. Led by a former head of worldwide clinical R&D at Pfizer, the firm supports companies across therapeutic areas, modalities, and development stages from early-stage technology platforms to late-stage clinical programs.
Firms observed investing alongside Amzak Health, from public investor directories. Shared companies are the overlap with Amzak Health's recorded portfolio.
Similar investors
Portfolia operates venture funds designed by and for women, enabling members to invest collectively in innovative companies while learning together through curated content, founder access, and hands-on deal flow.
WELL Health Ventures is the corporate venture arm of WELL Health Technologies, backing digital health companies with an emphasis on modernizing healthcare in Canada.
Ontario Centre of Innovation (OCI) is a government-supported organization that funds and supports innovation, academic-industry collaboration, and commercialization of technologies among Ontario companies.
Heliad is a publicly listed evergreen investment firm that backs founders from early stage through IPO and beyond, providing access to capital markets via its balance sheet and its early-stage vehicle Collective Ventures.
500 Global (formerly 500 Startups) is a venture capital firm whose flagship Silicon Valley strategy backs promising technology companies from pre-seed onward across a range of sectors and geographies.